Sodium 2-benzamidoacetate, 95+%, 100g

(S)-BINAP, min. 98%, 250 mg, glass packaging

SODIUM 2-METHYL-4,5-DIHYDRO-1,3-THIAZOLE-4-CARBOXYLATE, 95%, 1g

N-(2,6-DICHLORO-2'-(TRIFLUOROMETHOXY)-[1,1'-BIPHENYL]-4-YL)-2-(4-(ETHYLSULFONYL)PHENYL)ACETAMIDE, 95%, 250mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(((benzyloxy)carbonyl)amino)butanoic acid, 97%, 5g

N1,N4-DICYCLOPROPYL-2,3-DIHYDROXYSUCCINAMIDE, 95.0%, 1g

tert-Butyl cis-4-aminomethylcyclohexylcarbamate, 95.0%, 1g

N-[(4-Fluorophenyl)methyl]piperazine-1-carboxamide hydrochloride, 1g

bScope BS.1152-PLPHi for phase contrast. Biocular with HWF 10x/20 mm eyepieces and Fivefold revolver E-plan Phase IOS 10/20/S40 S100x

Ethyl 1H-pyrazolo[4,3-b]pyridine-3-carboxylate, 95.0%, 250mg

(2-Fluoro-6-methylphenyl)methanol, 95.0%, 5g

Molybdenum wire 99.95% 2.0 mm diameter 5 m

Ammonia D3 solution 25% in D2O, 99 at%D, 10 ml, glass packaging